A study showed that CBD endocannabinoid decreases breast cancer aggressiveness by downregulating the helix–loop–helix protein Id-1, an inhibitor of basic helix–loop–helix transcription factors that promote human breast cancer progression [20]. The gene discussed is ID1; the disease is breast carcinoma.